Profil
Cornelia Haag-Molkenteller is currently the Chief Medical Officer at Urovant Sciences, Inc. and the Chief Medical Officer & Executive Vice President at Urovant Sciences Ltd. Prior to her current positions, she worked at Allergan Ltd. (Ireland) as Vice President-Clinical Development from 2015 to 2018 and at Schwarz BioSciences GmbH as Vice President-Clinical Program from 1988 to 2006.
She holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Postes actifs de Cornelia Haag-Molkenteller
| Sociétés | Poste | Début |
|---|---|---|
| UROVANT SCIENCES LTD. | Directeur Technique/Scientifique/R&D | 01/04/2018 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Directeur Technique/Scientifique/R&D | 01/04/2018 |
Anciens postes connus de Cornelia Haag-Molkenteller
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | 01/03/2018 |
Schwarz BioSciences GmbH | Corporate Officer/Principal | 01/01/2006 |
Formation de Cornelia Haag-Molkenteller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Schwarz BioSciences GmbH | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
















